Heart Attack and Pneumonia Recovery Study With Vaccination
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male patient under 65 years old
- You currently smoke or have been an active smoker
- You have been diagnosed with both acute coronary syndrome (a type of heart attack) and pneumonia
- You have improved and stabilized after treatment in the hospital
- You are willing to receive vaccinations and attend all follow-up visits
- You do not have a severe allergy history to vaccines or serious conditions like cancer, kidney failure, or liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether getting a flu vaccine helps people who recently had a heart attack or unstable angina (acute coronary syndrome). It looks at whether vaccination can reduce future heart problems.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This trial tests a new way to diagnose and treat chronic obstructive pulmonary disease (COPD) flare-ups (sudden worsening of symptoms). It aims to help people who come to the emergency room with a COPD flare-up get better care and follow-up.
This study looks at how well different treatments work for people with lung infections or sudden worsening of chronic lung disease. If you have a respiratory sample available and are about to start an antibiotic, antiviral, antifungal, or steroid, you may be able to join.
This is a retrospective study (looking back at past patient records) of people hospitalized with pneumonia to understand how the disease progresses and what factors affect recovery. Researchers will examine medical records of pneumonia patients admitted within 72 hours of symptom onset to identify patterns in who recovers well and who develops serious complications.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.